25 XP   0   0   10

Bio-Gene Technology Ltd
Buy, Hold or Sell?

Let's analyse Bio-gene together

PenkeI guess you are interested in Bio-Gene Technology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bio-Gene Technology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bio-Gene Technology Ltd

I send you an email if I find something interesting about Bio-Gene Technology Ltd.

Quick analysis of Bio-gene (30 sec.)










What can you expect buying and holding a share of Bio-gene? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.02
Expected worth in 1 year
A$-0.04
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.06
Return On Investment
-80.7%

For what price can you sell your share?

Current Price per Share
A$0.08
Expected price per share
A$0.056 - A$0.085
How sure are you?
50%

1. Valuation of Bio-gene (5 min.)




Live pricePrice per Share (EOD)

A$0.08

Intrinsic Value Per Share

A$-0.16 - A$-0.09

Total Value Per Share

A$-0.15 - A$-0.07

2. Growth of Bio-gene (5 min.)




Is Bio-gene growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$4m-$1.9m-94.6%

How much money is Bio-gene making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$1.7m-$188.6k-9.5%
Net Profit Margin-520.2%-318.5%--

How much money comes from the company's main activities?

3. Financial Health of Bio-gene (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#816 / 1014

Most Revenue
#568 / 1014

Most Profit
#298 / 1014

Most Efficient
#749 / 1014

What can you expect buying and holding a share of Bio-gene? (5 min.)

Welcome investor! Bio-gene's management wants to use your money to grow the business. In return you get a share of Bio-gene.

What can you expect buying and holding a share of Bio-gene?

First you should know what it really means to hold a share of Bio-gene. And how you can make/lose money.

Speculation

The Price per Share of Bio-gene is A$0.075. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bio-gene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bio-gene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.02. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bio-gene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-13.2%-0.01-13.2%-0.01-12.4%-0.01-10.5%-0.01-7.1%
Usd Book Value Change Per Share-0.01-13.0%-0.01-13.0%0.018.6%0.00-3.1%0.001.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.3%0.000.1%0.000.0%
Usd Total Gains Per Share-0.01-13.0%-0.01-13.0%0.018.9%0.00-3.0%0.001.4%
Usd Price Per Share0.05-0.05-0.08-0.08-0.05-
Price to Earnings Ratio-5.07--5.07--8.98--10.14--6.24-
Price-to-Total Gains Ratio-5.15--5.15-12.48-0.60--2.06-
Price to Book Ratio4.88-4.88-4.18-5.03-2.99-
Price-to-Total Gains Ratio-5.15--5.15-12.48-0.60--2.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0481575
Number of shares20765
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (20765 shares)-201.77-47.48
Gains per Year (20765 shares)-807.06-189.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-807-8175-195-200
20-1614-162411-391-390
30-2421-243116-586-580
40-3228-323821-781-770
50-4035-404527-976-960
60-4842-485232-1172-1150
70-5649-565937-1367-1340
80-6457-646643-1562-1530
90-7264-727348-1757-1720
100-8071-808053-1953-1910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%3.00.02.060.0%3.00.07.030.0%3.00.07.030.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%6.04.00.060.0%

Fundamentals of Bio-gene

About Bio-Gene Technology Ltd

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-04-10 00:17:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bio-Gene Technology Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bio-gene earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • A Net Profit Margin of -520.2% means that $-5.20 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bio-Gene Technology Ltd:

  • The MRQ is -520.2%. The company is making a huge loss. -2
  • The TTM is -520.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-520.2%TTM-520.2%0.0%
TTM-520.2%YOY-318.5%-201.7%
TTM-520.2%5Y-366.7%-153.5%
5Y-366.7%10Y-16,945.8%+16,579.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-520.2%-196.1%-324.1%
TTM-520.2%-211.9%-308.3%
YOY-318.5%-277.7%-40.8%
5Y-366.7%-432.9%+66.2%
10Y-16,945.8%-599.3%-16,346.5%
1.1.2. Return on Assets

Shows how efficient Bio-gene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • -80.7% Return on Assets means that Bio-gene generated $-0.81 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bio-Gene Technology Ltd:

  • The MRQ is -80.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -80.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-80.7%TTM-80.7%0.0%
TTM-80.7%YOY-38.4%-42.4%
TTM-80.7%5Y-45.8%-34.9%
5Y-45.8%10Y-36.8%-9.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-80.7%-13.3%-67.4%
TTM-80.7%-12.7%-68.0%
YOY-38.4%-11.8%-26.6%
5Y-45.8%-14.0%-31.8%
10Y-36.8%-15.9%-20.9%
1.1.3. Return on Equity

Shows how efficient Bio-gene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • -96.1% Return on Equity means Bio-gene generated $-0.96 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bio-Gene Technology Ltd:

  • The MRQ is -96.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -96.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-96.1%TTM-96.1%0.0%
TTM-96.1%YOY-44.7%-51.4%
TTM-96.1%5Y-53.3%-42.8%
5Y-53.3%10Y-44.0%-9.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.1%-16.9%-79.2%
TTM-96.1%-16.0%-80.1%
YOY-44.7%-15.1%-29.6%
5Y-53.3%-19.7%-33.6%
10Y-44.0%-20.5%-23.5%

1.2. Operating Efficiency of Bio-Gene Technology Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bio-gene is operating .

  • Measures how much profit Bio-gene makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • An Operating Margin of -534.7% means the company generated $-5.35  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bio-Gene Technology Ltd:

  • The MRQ is -534.7%. The company is operating very inefficient. -2
  • The TTM is -534.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-534.7%TTM-534.7%0.0%
TTM-534.7%YOY-338.0%-196.7%
TTM-534.7%5Y-394.3%-140.4%
5Y-394.3%10Y-24,364.4%+23,970.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-534.7%-290.9%-243.8%
TTM-534.7%-224.4%-310.3%
YOY-338.0%-288.3%-49.7%
5Y-394.3%-479.5%+85.2%
10Y-24,364.4%-625.2%-23,739.2%
1.2.2. Operating Ratio

Measures how efficient Bio-gene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.87 means that the operating costs are $6.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 6.874. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.874. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.874TTM6.8740.000
TTM6.874YOY4.684+2.190
TTM6.8745Y5.253+1.621
5Y5.25310Y252.471-247.218
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8743.110+3.764
TTM6.8743.266+3.608
YOY4.6843.783+0.901
5Y5.2535.657-0.404
10Y252.4717.783+244.688

1.3. Liquidity of Bio-Gene Technology Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bio-gene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.24 means the company has $6.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 6.239. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.239. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.239TTM6.2390.000
TTM6.239YOY6.939-0.700
TTM6.2395Y9.429-3.189
5Y9.42910Y24.745-15.317
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2393.905+2.334
TTM6.2394.212+2.027
YOY6.9395.337+1.602
5Y9.4296.062+3.367
10Y24.7456.401+18.344
1.3.2. Quick Ratio

Measures if Bio-gene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • A Quick Ratio of 5.99 means the company can pay off $5.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 5.988. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.988. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.988TTM5.9880.000
TTM5.988YOY6.792-0.804
TTM5.9885Y11.692-5.705
5Y11.69210Y16.216-4.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9883.572+2.416
TTM5.9884.001+1.987
YOY6.7925.364+1.428
5Y11.6926.009+5.683
10Y16.2166.287+9.929

1.4. Solvency of Bio-Gene Technology Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bio-gene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bio-gene to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.16 means that Bio-gene assets are financed with 16.0% credit (debt) and the remaining percentage (100% - 16.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 0.160. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.160. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.1600.000
TTM0.160YOY0.142+0.018
TTM0.1605Y0.130+0.030
5Y0.13010Y0.124+0.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1600.336-0.176
TTM0.1600.334-0.174
YOY0.1420.271-0.129
5Y0.1300.366-0.236
10Y0.1240.389-0.265
1.4.2. Debt to Equity Ratio

Measures if Bio-gene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • A Debt to Equity ratio of 19.1% means that company has $0.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 0.191. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.191. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.191TTM0.1910.000
TTM0.191YOY0.165+0.026
TTM0.1915Y0.150+0.040
5Y0.15010Y0.172-0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1910.382-0.191
TTM0.1910.397-0.206
YOY0.1650.341-0.176
5Y0.1500.432-0.282
10Y0.1720.465-0.293

2. Market Valuation of Bio-Gene Technology Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bio-gene generates.

  • Above 15 is considered overpriced but always compare Bio-gene to the Biotechnology industry mean.
  • A PE ratio of -5.07 means the investor is paying $-5.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bio-Gene Technology Ltd:

  • The EOD is -4.878. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.073. Based on the earnings, the company is expensive. -2
  • The TTM is -5.073. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.878MRQ-5.073+0.195
MRQ-5.073TTM-5.0730.000
TTM-5.073YOY-8.983+3.909
TTM-5.0735Y-10.140+5.066
5Y-10.14010Y-6.243-3.897
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.878-2.262-2.616
MRQ-5.073-2.599-2.474
TTM-5.073-2.674-2.399
YOY-8.983-4.133-4.850
5Y-10.140-6.258-3.882
10Y-6.243-6.171-0.072
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bio-Gene Technology Ltd:

  • The EOD is -4.609. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.794. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.794. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.609MRQ-4.794+0.184
MRQ-4.794TTM-4.7940.000
TTM-4.794YOY713.758-718.551
TTM-4.7945Y-1,216.557+1,211.764
5Y-1,216.55710Y-609.550-607.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.609-2.913-1.696
MRQ-4.794-3.275-1.519
TTM-4.794-3.508-1.286
YOY713.758-5.620+719.378
5Y-1,216.557-8.306-1,208.251
10Y-609.550-8.854-600.696
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bio-gene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.88 means the investor is paying $4.88 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bio-Gene Technology Ltd:

  • The EOD is 4.688. Based on the equity, the company is fair priced.
  • The MRQ is 4.876. Based on the equity, the company is fair priced.
  • The TTM is 4.876. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.688MRQ4.876-0.188
MRQ4.876TTM4.8760.000
TTM4.876YOY4.176+0.700
TTM4.8765Y5.027-0.152
5Y5.02710Y2.995+2.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6881.858+2.830
MRQ4.8762.090+2.786
TTM4.8762.091+2.785
YOY4.1762.866+1.310
5Y5.0273.488+1.539
10Y2.9953.836-0.841
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bio-Gene Technology Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bio-Gene Technology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.015-0.0150%0.010-251%-0.004-76%0.002-1046%
Book Value Per Share--0.0160.0160%0.031-49%0.025-35%0.021-23%
Current Ratio--6.2396.2390%6.939-10%9.429-34%24.745-75%
Debt To Asset Ratio--0.1600.1600%0.142+13%0.130+23%0.124+29%
Debt To Equity Ratio--0.1910.1910%0.165+15%0.150+27%0.172+11%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Eps---0.015-0.0150%-0.014-6%-0.012-20%-0.008-46%
Free Cash Flow Per Share---0.016-0.0160%0.000-9033%-0.007-59%-0.005-67%
Free Cash Flow To Equity Per Share---0.017-0.0170%0.022-175%0.001-3285%0.004-563%
Gross Profit Margin--1.0991.0990%1.151-5%1.108-1%1.054+4%
Intrinsic Value_10Y_max---0.086--------
Intrinsic Value_10Y_min---0.162--------
Intrinsic Value_1Y_max---0.007--------
Intrinsic Value_1Y_min---0.010--------
Intrinsic Value_3Y_max---0.023--------
Intrinsic Value_3Y_min---0.037--------
Intrinsic Value_5Y_max---0.039--------
Intrinsic Value_5Y_min---0.068--------
Market Cap15102150.000-4%15706236.00015706236.0000%26177060.000-40%24082895.200-35%15363920.600+2%
Net Profit Margin---5.202-5.2020%-3.185-39%-3.667-30%-169.458+3157%
Operating Margin---5.347-5.3470%-3.380-37%-3.943-26%-243.644+4456%
Operating Ratio--6.8746.8740%4.684+47%5.253+31%252.471-97%
Pb Ratio4.688-4%4.8764.8760%4.176+17%5.027-3%2.995+63%
Pe Ratio-4.878+4%-5.073-5.0730%-8.983+77%-10.140+100%-6.243+23%
Price Per Share0.075-4%0.0780.0780%0.130-40%0.120-35%0.076+2%
Price To Free Cash Flow Ratio-4.609+4%-4.794-4.7940%713.758-101%-1216.557+25278%-609.550+12615%
Price To Total Gains Ratio-4.956+4%-5.154-5.1540%12.481-141%0.598-962%-2.060-60%
Quick Ratio--5.9885.9880%6.792-12%11.692-49%16.216-63%
Return On Assets---0.807-0.8070%-0.384-52%-0.458-43%-0.368-54%
Return On Equity---0.961-0.9610%-0.447-53%-0.533-45%-0.440-54%
Total Gains Per Share---0.015-0.0150%0.010-245%-0.004-76%0.002-1017%
Usd Book Value--2068428.1932068428.1930%4024986.513-49%3170403.295-35%2688105.290-23%
Usd Book Value Change Per Share---0.010-0.0100%0.006-251%-0.002-76%0.001-1046%
Usd Book Value Per Share--0.0100.0100%0.020-49%0.016-35%0.013-23%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Eps---0.010-0.0100%-0.009-6%-0.008-20%-0.005-46%
Usd Free Cash Flow---2103746.903-2103746.9030%23549.018-9033%-862417.737-59%-687984.145-67%
Usd Free Cash Flow Per Share---0.010-0.0100%0.000-9033%-0.004-59%-0.003-67%
Usd Free Cash Flow To Equity Per Share---0.011-0.0110%0.014-175%0.000-3285%0.002-563%
Usd Market Cap9697090.515-4%10084974.13610084974.1360%16808290.226-40%15463627.008-35%9865173.417+2%
Usd Price Per Share0.048-4%0.0500.0500%0.083-40%0.077-35%0.049+2%
Usd Profit---1987801.622-1987801.6220%-1799155.853-9%-1546882.211-22%-1055710.577-47%
Usd Revenue--382099.584382099.5840%564904.170-32%444886.819-14%241771.261+58%
Usd Total Gains Per Share---0.010-0.0100%0.007-245%-0.002-76%0.001-1017%
 EOD+3 -5MRQTTM+0 -0YOY+2 -345Y+2 -3410Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Bio-Gene Technology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.878
Price to Book Ratio (EOD)Between0-14.688
Net Profit Margin (MRQ)Greater than0-5.202
Operating Margin (MRQ)Greater than0-5.347
Quick Ratio (MRQ)Greater than15.988
Current Ratio (MRQ)Greater than16.239
Debt to Asset Ratio (MRQ)Less than10.160
Debt to Equity Ratio (MRQ)Less than10.191
Return on Equity (MRQ)Greater than0.15-0.961
Return on Assets (MRQ)Greater than0.05-0.807
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Bio-Gene Technology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.075
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets3,835
Total Liabilities614
Total Stockholder Equity3,221
 As reported
Total Liabilities 614
Total Stockholder Equity+ 3,221
Total Assets = 3,835

Assets

Total Assets3,835
Total Current Assets3,580
Long-term Assets255
Total Current Assets
Cash And Cash Equivalents 2,991
Net Receivables 446
Inventory 70
Other Current Assets 74
Total Current Assets  (as reported)3,580
Total Current Assets  (calculated)3,580
+/-0
Long-term Assets
Property Plant Equipment 15
Intangible Assets 240
Long-term Assets  (as reported)255
Long-term Assets  (calculated)255
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities574
Long-term Liabilities40
Total Stockholder Equity3,221
Total Current Liabilities
Accounts payable 119
Other Current Liabilities 455
Total Current Liabilities  (as reported)574
Total Current Liabilities  (calculated)574
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)40
Long-term Liabilities  (calculated)0
+/- 40
Total Stockholder Equity
Common Stock19,546
Retained Earnings -17,432
Accumulated Other Comprehensive Income 1,108
Total Stockholder Equity (as reported)3,221
Total Stockholder Equity (calculated)3,221
+/-0
Other
Capital Stock19,546
Cash and Short Term Investments 2,991
Common Stock Shares Outstanding 167,768
Liabilities and Stockholders Equity 3,835
Net Debt -2,991
Net Invested Capital 3,221
Net Working Capital 3,007
Property Plant and Equipment Gross 51



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-30
> Total Assets 
291
435
856
9,445
7,667
5,563
6,570
5,001
7,303
3,835
3,8357,3035,0016,5705,5637,6679,445856435291
   > Total Current Assets 
101
297
330
8,953
7,203
5,142
6,182
4,664
7,003
3,580
3,5807,0034,6646,1825,1427,2038,953330297101
       Cash And Cash Equivalents 
51
209
102
8,793
6,707
4,499
5,522
3,933
6,342
2,991
2,9916,3423,9335,5224,4996,7078,79310220951
       Short-term Investments 
0
0
0
2,000
6,470
0
5,300
0
74
0
07405,30006,4702,000000
       Net Receivables 
0
9
228
161
368
473
483
524
438
446
44643852448347336816122890
       Other Current Assets 
50
79
186
0
128
74
74
74
74
74
747474747412801867950
   > Long-term Assets 
0
0
0
492
463
421
388
337
300
255
255300337388421463492000
       Property Plant Equipment 
8
7
28
30
39
33
37
23
23
15
152323373339302878
       Intangible Assets 
182
132
499
462
425
388
351
314
277
240
240277314351388425462499132182
> Total Liabilities 
1
0
383
374
760
614
567
755
1,035
614
6141,03575556761476037438301
   > Total Current Liabilities 
1
0
7
224
610
464
412
593
1,009
574
5741,009593412464610224701
       Short-term Debt 
0
0
0
0
0
0
12
0
0
0
00012000000
       Accounts payable 
0
0
0
47
185
123
134
88
219
119
1192198813412318547000
       Other Current Liabilities 
1
0
7
403
425
340
266
505
790
455
455790505266340425403701
   > Long-term Liabilities 
0
0
0
150
150
150
155
162
25
40
4025162155150150150000
       Long term Debt Total 
0
0
0
150
150
150
150
150
0
0
00150150150150150000
       Other Liabilities 
0
0
376
150
150
150
155
162
25
0
02516215515015015037600
> Total Stockholder Equity
290
435
473
9,071
6,907
4,949
6,002
4,246
6,268
3,221
3,2216,2684,2466,0024,9496,9079,071473435290
   Common Stock
1,265
1,550
1,779
11,956
11,769
11,804
14,536
15,062
19,546
19,546
19,54619,54615,06214,53611,80411,76911,9561,7791,5501,265
   Retained Earnings -17,432-14,499-11,679-9,483-7,551-5,495-2,960-1,607-1,115-975
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
301
366
634
696
950
863
1,222
818
8181,22286395069663436630100



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue595
Cost of Revenue-313
Gross Profit282282
 
Operating Income (+$)
Gross Profit282
Operating Expense-3,777
Operating Income-3,182-3,495
 
Operating Expense (+$)
Research Development1,979
Selling General Administrative478
Selling And Marketing Expenses307
Operating Expense3,7772,763
 
Net Interest Income (+$)
Interest Income86
Interest Expense-0
Other Finance Cost-0
Net Interest Income86
 
Pretax Income (+$)
Operating Income-3,182
Net Interest Income86
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,096-3,182
EBIT - interestExpense = -3,182
-3,182
-3,096
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-3,182-3,096
Earnings Before Interest and Taxes (EBITDA)-3,137
 
After tax Income (+$)
Income Before Tax-3,096
Tax Provision-0
Net Income From Continuing Ops-3,096-3,096
Net Income-3,096
Net Income Applicable To Common Shares-3,096
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,777
Total Other Income/Expenses Net0-86
 

Technical Analysis of Bio-gene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bio-gene. The general trend of Bio-gene is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bio-gene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bio-Gene Technology Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.083 < 0.085 < 0.085.

The bearish price targets are: 0.06 > 0.06 > 0.056.

Tweet this
Bio-Gene Technology Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bio-Gene Technology Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bio-Gene Technology Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBio-Gene Technology Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bio-Gene Technology Ltd. The current adx is .

Bio-Gene Technology Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Relative Strength Index (RSI) ChartBio-Gene Technology Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Stochastic Oscillator ChartBio-Gene Technology Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Commodity Channel Index (CCI) ChartBio-Gene Technology Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Chande Momentum Oscillator (CMO) ChartBio-Gene Technology Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Williams %R ChartBio-Gene Technology Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Average True Range (ATR) ChartBio-Gene Technology Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily On-Balance Volume (OBV) ChartBio-Gene Technology Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Money Flow Index (MFI) ChartBio-Gene Technology Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bio-Gene Technology Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Bio-Gene Technology Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bio-Gene Technology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.075
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bio-gene with someone you think should read this too:
  • Are you bullish or bearish on Bio-gene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bio-gene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bio-Gene Technology Ltd

I send you an email if I find something interesting about Bio-Gene Technology Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Bio-Gene Technology Ltd.

Receive notifications about Bio-Gene Technology Ltd in your mailbox!